We are analyzing https://link.springer.com/article/10.1007/bf00607425.

Title:
The influence of prolonged treatment with D-penicillamine on the immune response in Wilson's disease | European Journal of Clinical Pharmacology
Description:
European Journal of Clinical Pharmacology - Humoral and cell-mediated immunity were studied in a group of patients with Wilson
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

google, scholar, article, dpenicillamine, disease, wilsons, med, response, treatment, członkowska, patients, lymphocyte, privacy, cookies, content, journal, immune, humoral, immunity, penicillamine, access, publish, search, influence, cellmediated, antigen, transformation, rheumatoid, arthritis, data, european, information, log, research, antibodies, normal, studies, inhibition, discover, pol, walshe, clin, download, springer, function, optional, personal, parties, policy, find,

Topics {✒️}

studies with35s-labelled dl-penicillamine month download article/chapter cell-mediated immunity related subjects tuberculin-induced migration inhibition humoral response returned privacy choices/manage cookies article european journal full article pdf european economic area mitogen-induced proliferation clinical pharmacology aims adult healthy groups pyridoxine deficient rats chronic aggressive hepatitis anglo-american adventure conditions privacy policy july 1977 volume 12 human peripheral leucocytes enterobacteriaceae common antigen journal finder publish accepting optional cookies article członkowska main content log decreased lymphocyte transformation vitro lymphocyte transformation disease originals published check access instant access disease access article log immune response privacy policy personal data article cite books a d-penicillamine migration inhibition decreased response journal publish vitro studies optional cookies manage preferences previously treated lymphocyte transformation reduced response data protection essential cookies cookies skip subscription content

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The influence of prolonged treatment with D-penicillamine on the immune response in Wilson's disease
         description:Humoral and cell-mediated immunity were studied in a group of patients with Wilson's disease not previously treated with D-penicillamine, and in a group of patients treated with the drug for more than two years. The previously untreated patients showed an exaggerated humoral immune response, i. e. increased levels of IgG and, IgM, higher titer of antibodies to Kunin's antigen, and depression of cell-mediated immunity, namely a decreased response to DNCB, decreased lymphocyte transformation after stimulation with Con A, PPD, Candida and streptokinase and a reduced response to streptokinase in the MIF test. After treatment the humoral response returned to normal, and in the case of IgA and antibodies to S. typhi O antigen, it even dropped below normal values. The cell-mediated immune response returned to normal with the exception of lymphocyte transformation by PHA and Candida albicans. In in vitro studies it was found that D-penicillamine had no influence on lymphocyte transformation when PHA and Con A were used as mitogens. With PPD as antigen, lymphocyte stimulation and migration inhibition were inhibited by concentrations of penicillamine ranging from 6 to 1000 µg/ml.
         datePublished:
         dateModified:
         pageStart:265
         pageEnd:271
         sameAs:https://doi.org/10.1007/BF00607425
         keywords:
            Humoral immunity
            cell-mediated immunity
            D-penicillamine
            Wilson's disease
            Pharmacology/Toxicology
         image:
         isPartOf:
            name:European Journal of Clinical Pharmacology
            issn:
               1432-1041
               0031-6970
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Anna Członkowska
               affiliation:
                     name:Psychoneurological Institute
                     address:
                        name:Department of Genetics, Psychoneurological Institute, Warsaw, Poland
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The influence of prolonged treatment with D-penicillamine on the immune response in Wilson's disease
      description:Humoral and cell-mediated immunity were studied in a group of patients with Wilson's disease not previously treated with D-penicillamine, and in a group of patients treated with the drug for more than two years. The previously untreated patients showed an exaggerated humoral immune response, i. e. increased levels of IgG and, IgM, higher titer of antibodies to Kunin's antigen, and depression of cell-mediated immunity, namely a decreased response to DNCB, decreased lymphocyte transformation after stimulation with Con A, PPD, Candida and streptokinase and a reduced response to streptokinase in the MIF test. After treatment the humoral response returned to normal, and in the case of IgA and antibodies to S. typhi O antigen, it even dropped below normal values. The cell-mediated immune response returned to normal with the exception of lymphocyte transformation by PHA and Candida albicans. In in vitro studies it was found that D-penicillamine had no influence on lymphocyte transformation when PHA and Con A were used as mitogens. With PPD as antigen, lymphocyte stimulation and migration inhibition were inhibited by concentrations of penicillamine ranging from 6 to 1000 µg/ml.
      datePublished:
      dateModified:
      pageStart:265
      pageEnd:271
      sameAs:https://doi.org/10.1007/BF00607425
      keywords:
         Humoral immunity
         cell-mediated immunity
         D-penicillamine
         Wilson's disease
         Pharmacology/Toxicology
      image:
      isPartOf:
         name:European Journal of Clinical Pharmacology
         issn:
            1432-1041
            0031-6970
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Anna Członkowska
            affiliation:
                  name:Psychoneurological Institute
                  address:
                     name:Department of Genetics, Psychoneurological Institute, Warsaw, Poland
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:European Journal of Clinical Pharmacology
      issn:
         1432-1041
         0031-6970
      volumeNumber:12
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Psychoneurological Institute
      address:
         name:Department of Genetics, Psychoneurological Institute, Warsaw, Poland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Anna Członkowska
      affiliation:
            name:Psychoneurological Institute
            address:
               name:Department of Genetics, Psychoneurological Institute, Warsaw, Poland
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Genetics, Psychoneurological Institute, Warsaw, Poland
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(48)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.99s.

LINK . SPRINGER . COM {}